Navigation Links
CareGiver, Ventana Medical Systems, Inc. Remote Instrument Support, Has Expanded to Include the Ventana BenchMark ULTRA Automated Stainer
Date:1/13/2011

TUCSON, Ariz., Jan. 13, 2011 /PRNewswire/ -- CareGiver remote instrument support has expanded to include the Ventana BenchMark ULTRA automated stainer. Ventana Medical System, Inc. ("VMSI") is the leading innovator in the application of remote services for histology with over 5 years of success on the SYMPHONY H&E slide stainer. VMSI is now introducing remote service monitoring on BenchMark ULTRA, strengthening the integration of the SYMPHONY and BenchMark platforms. For customers, CareGiver reduces the prospect of unwanted surprises by monitoring instrument performance 24/7. "CareGiver changes the traditional service model from reactive to proactive," added Dave Flaten, International Business Leader for VMSI's Advanced Staining Platforms. "Customers are delighted when we call them to troubleshoot an instrument issue before they are aware of it. The integration of CareGiver remote instrument support on two key VMSI platforms will continue to drive financial performance, improve customer satisfaction, and further differentiate VMSI products from competitive systems and services," Flaten added.

When a laboratory instrument fails to perform as expected, documenting the issue with customer support, ordering parts, and waiting for an engineer to be dispatched can be an inconvenient and costly proposition for the lab, as the devices that facilitate reporting of patient results are mission critical. With CareGiver remote instrument support, VMSI continues to innovate the way customers experience the delivery of service for their instruments, as the VMSI customer support team can proactively monitor instrument performance remotely from their location in Tucson. "Increased uptime and access to instruments translate into improved customer satisfaction and increased productivity, which ultimately contributes to our key results," Flaten commented.

CareGiver Delivers Key Results

VMSI's innovative approach to service delivery allows the company to grow revenue through creative service offerings, differentiating products, and driving product and service revenue through increased maintenance contract renewals.

Moreover, the value of continuous remote services is in the reduction of services costs through improved analysis and dispatching of field resources, such that when service engineers are dispatched to a site, issues will already be remotely diagnosed, parts ordered, and materials delivered. The current practice of dispatching resources, having the field service engineer define and diagnose issues onsite, and then ordering the part for later repair wastes considerable time and money from a service perspective. Additionally, it creates an overall negative experience for the customer. CareGiver delivers a whole new paradigm of service delivery.

CareGiver remote instrument support is being commercialized on BenchMark ULTRA platform through a phased implementation approach. The service will be provided for North American systems in Q4 2010, with a planned launch in Europe and the rest of the world in early 2011. Ventana looks forward to continuing its expansion of CareGiver to more products in the advanced staining portfolio and expanding the application's capabilities on both Ventana SYMPHONY and BenchMark ULTRA stainers, effectively enhancing both its commercial objectives and customers' experiences in the process.

About Ventana Medical Systems, Inc.

Ventana Medical Systems, Inc. ("VMSI") develops, manufactures, and markets instrument/reagent systems that automate tissue preparation and slide staining in clinical histology and drug discovery laboratories worldwide. The Company's clinical systems are important tools used in the diagnosis and treatment of cancer and infectious diseases. VMSI's drug discovery systems are used to accelerate the discovery of new drug targets and evaluate the safety of new drug compounds. In addition, the Company offers premier workflow solutions designed to improve laboratory efficiency, providing safeguards to enhance the quality of healthcare. Ventana Medical Systems, Inc. is a wholly-owned member of the Roche Group. For more information on Ventana Medical Systems, Inc. visit www.ventanamed.com.

Ventana, the Ventana logo, SYMPHONY, and BenchMark are trademarks of Roche.


'/>"/>
SOURCE Ventana Medical Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Endologix Announces First Clinical Implant of Ventana™ Stent Graft
2. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
3. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
4. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
5. Globus Medical Raises $110 Million in Series E Financing Round
6. Quark Pharmaceuticals Appoints New Chief Medical Officer
7. Boston University Biomedical Engineers Find Chink in Bacterias Armor
8. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
9. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
10. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
11. Cleveland Clinic Summits to Focus on Cardiovascular Medical Innovation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... MedDay, a biotechnology company focused on the treatment ... "High doses of biotin in progressive multiple sclerosis: extension phase ... Ayman Tourbah , Principal Investigator of the Phase 3 ... Neurology (EAN) in Copenhagen, Denmark . The ... on Sunday, 29 May 2016 from 14:45 to 16:15 CEST ...
(Date:5/24/2016)... --   , ... Endpunkte und demonstriert Ebenbürtigkeit bei der Gesamtreinigung des ... guter , Reinigung des ... (Logo: http://photos.prnewswire.com/prnh/20130829/633895-a ) , ... der MORA-Studie der Phase III für NER1006 (1 ...
(Date:5/24/2016)... Celsion Corporation (NASDAQ: CLSN ... an update on its ongoing OVATION study, a ... the Company,s DNA-based immunotherapy, with the standard of ... advanced ovarian cancer who will undergo neoadjuvant chemotherapy ... IL-12 DNA plasmid vector formulated as a nanoparticle ...
Breaking Medicine Technology:
(Date:5/27/2016)... ... 27, 2016 , ... More than a third of American adults are considered ... surgery has received increased attention in recent years, as an article published ... weight loss, most people are familiar with the basic requirements of maintaining a healthy ...
(Date:5/27/2016)... ... ... With over 60 percent of acute stroke survivors being left unable to ... in the rehabilitation process has steadily increased. Ekso Bionics had been working to help ... stroke. , Ekso Bionics has now received clearance from the U.S. Food and Drug ...
(Date:5/27/2016)... ... May 27, 2016 , ... Aimed ... by inspiring human interest stories, courtesy of leaders in the nursing and health ... the industry, from leading advocates and associations—namely Jones & Bartlett Learning. , Jones ...
(Date:5/26/2016)... ... ... There are many ways to cook a hot dog, but new research commissioned ... dogs straight off the grill. Of the 90 percent of Americans who say they ... hot dog, far outpacing other cooking methods such as steaming (12 percent), microwaving (9 ...
(Date:5/26/2016)... , ... May 26, 2016 , ... Connor Sports, ... basketball as a partner for the Tamika Catchings Legacy Tour that will ... industry leader in hardwood basketball surfaces in all forms and levels of the game, ...
Breaking Medicine News(10 mins):